Salvia BioElectronics
PrivateLast Round
Series B
May 27, 2025
Total Funding Raised
$98.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Salvia BioElectronics is a medical device company that develops minimally invasive, ultra-thin implantable neuromodulation technology to treat chronic migraines and cluster headaches.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salvia BioElectronics Comparables
Compare Salvia BioElectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ShiraTronics | 92% | |
| Neurolief | 72% | |
| Precisis GmbH | 63% |
Salvia BioElectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2025 | ||||
| Debt | Sep 22, 2020 | ||||
| Series A | Sep 22, 2020 | ||||
| Seed | May 23, 2018 |
Key People
Founding team and executive leadership
Salvia BioElectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B |
| SHS Gesellschaft für Beteiligungsmanagement mbH | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B, Seed |
| Dolby Family Ventures | Series B, Series A |
| Brabantse Ontwikkelings Maatschappij | Series B |
| Invest-NL | Series B |
| My Global Family Office | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 647% MoM, reaching 11.8K.
- Jun 25, 2026
Grew 16% QoQ, from 67 to 78 employees.
Recent news
Latest coverage and updates
- hiresJul 7, 2026
Salvia BioElectronics B.V hires Jill Schiaparelli as Chair of the Board of Directors.
- is_developingJul 7, 2026
Salvia BioElectronics B.V is developing MySalvia Therapy.
Salvia BioElectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Salvia BioElectronics's valuation, stock price, and market status.
Is Salvia BioElectronics a public or private company?
Salvia BioElectronics is a private company.
What is the current stock price of Salvia BioElectronics?
Salvia BioElectronics is a private company with no public stock price. No recent secondary market data is available.
How much is Salvia BioElectronics worth (valuation)?
Valuation information for Salvia BioElectronics is not publicly available.
Can I buy Salvia BioElectronics stock?
Salvia BioElectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Salvia BioElectronics's last funding round?
Salvia BioElectronics's most recent funding round was Series B on May 27, 2025.
Who are the main investors in Salvia BioElectronics?
Key investors in Salvia BioElectronics include SHS Gesellschaft für Beteiligungsmanagement mbH, Panakès Partners, Inkef Capital, Innovation Industries.
Will Salvia BioElectronics IPO soon?
No public IPO plans have been announced for Salvia BioElectronics.
How can I track Salvia BioElectronics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Salvia BioElectronics's secondary market activity and sign up for updates.